Group One Trading
KURA icon

Group One Trading’s Kura Oncology KURA Stock Holding History

Group One Trading’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,600
Closed -$45.5K – 8071
2026
Q1 		$45.5K Sell
5,600
-10,700
-66% -$91.9K ﹤0.01% 5328
2025
Q4 		$169K Buy
16,300
+10,600
+186% +$111K ﹤0.01% 4528
2025
Q3 		$50.4K Buy
5,700
+3,200
+128% +$22.8K ﹤0.01% 5955
2025
Q2 		$14.4K Buy
2,500
+1,300
+108% +$7.96K ﹤0.01% 6482
2025
Q1 		$7.92K Buy
1,200
+200
+20% +$1.56K ﹤0.01% 6404
2024
Q4 		$8.71K Buy
1,000
+900
+900% +$12.9K ﹤0.01% 6169
2024
Q3 		$1.95K Hold
100
– – ﹤0.01% 6151
2024
Q2 		$2.06K Sell
100
-17,700
-99% -$364K ﹤0.01% 6217
2024
Q1 		$380K Buy
+17,800
New +$346K ﹤0.01% 3000
2023
Q4 		– Sell
-6,000
Closed -$54.7K – 7800
2023
Q3 		$54.7K Buy
6,000
+3,900
+186% +$39.6K ﹤0.01% 5012
2023
Q2 		$22.2K Buy
+2,100
New +$24.8K ﹤0.01% 5924
2022
Q4 		– Sell
-10,000
Closed -$137K – 7685
2022
Q3 		$137K Hold
10,000
– – ﹤0.01% 4486
2022
Q2 		$183K Hold
10,000
– – ﹤0.01% 4391
2022
Q1 		$161K Buy
10,000
+4,900
+96% +$70.8K ﹤0.01% 5030
2021
Q4 		$71K Sell
5,100
-15,200
-75% -$246K ﹤0.01% 6038
2021
Q3 		$380K Sell
20,300
-400
-2% -$7.54K ﹤0.01% 4498
2021
Q2 		$432K Buy
+20,700
New +$514K ﹤0.01% 4374
2021
Q1 		– Sell
-17,200
Closed -$562K – 7797
2020
Q4 		$562K Buy
+17,200
New +$604K ﹤0.01% 3159
2020
Q3 		– Sell
-600
Closed -$10K – 6330
2020
Q2 		$10K Hold
600
– – ﹤0.01% 5124
2020
Q1 		$6K Buy
+600
New +$6.87K ﹤0.01% 4728
2018
Q4 		– Sell
-600
Closed -$11K – 5150
2018
Q3 		$11K Sell
600
-8,800
-94% -$169K ﹤0.01% 4622
2018
Q2 		$171K Buy
9,400
+6,800
+262% +$115K ﹤0.01% 3174
2018
Q1 		$49K Buy
2,600
+2,500
+2,500% +$48.7K ﹤0.01% 3665
2017
Q4 		$2K Buy
+100
New +$1.47K ﹤0.01% 4690

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Group One Trading's KURA Position: Q1 2026 in Review

Group One Trading sold out of Kura Oncology (KURA) in Q1 2026, closing a stake of 65,012 shares — an estimated $558K sold.

Group One Trading first reported a position in KURA in Q1 2018 and held it in 18 quarters. The position peaked at $678K in Q3 2025. 222 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Group One Trading reported no remaining Kura Oncology position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 65,012 Kura Oncology shares in Q1 2026, an estimated $558K.
  • Group One Trading first reported a position in Kura Oncology in Q1 2018 and held it in 18 quarters.
  • Group One Trading's Kura Oncology position peaked at $678K in Q3 2025.
  • 222 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.